NeuroPointDx

504 S. Rosa Rd. Suite 150 Madison, WI 53719

contact@NeuroPointDx.com

(608) 204-0104

CIC, One Broadway, Cambridge, MA 02142

NeuroPointDX, through its compound safety screening division, Stemina Biomarker Discovery, has developed the leading metabolomics platform for identifying differences in metabolism in children with ASD and other neuro-developmental disorders.

General Inquiries


Your Name (required)

Your Email (required)


Company/Affiliation

Subject


Your Message


Validation:

(608) 204-0104

504 S. Rosa Rd. Suite 150
Madison, WI 53719

contact@NeuroPointDx.com